TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP

Institutional investor · Portfolio as of Q3 2025

SEC EDGAR SourceSEC Filings

Top Holdings3,628 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

1M$680.4M1.0%$509.77+29.81%
28 qtrssince 2018-Q4
Decreased
0
XLFXLF
ETF

FINANCIAL SELECT SECTOR SPDR

10.8M$582.6M0.9%$53.45+0.91%
3 qtrssince 2025-Q1
Increased
72
XLPXLP
ETF

CONSUMER STAPLES SPDR

6.2M$489.6M0.7%$78.04-0.70%
2 qtrssince 2025-Q2
Increased
71
VUGVUG
ETF

VANGUARD GROWTH ETF

866,100$415.4M0.6%$59.72+33.42%
10 qtrssince 2023-Q2
Decreased
0
QQQQQQ
Unit

INVESCO QQQ TRUST SERIES 1 CL USD INC

673,858$404.6M0.6%$443.66+34.78%
27 qtrssince 2019-Q1
Decreased
0
QUALQUAL
ETF

ISHARES MSCI USA QUALITY FAC

1.9M$375.7M0.6%$176.97+8.93%
10 qtrssince 2023-Q2
Increased
71
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

500,700$335.1M0.5%$518.59+28.12%
10 qtrssince 2023-Q2
Decreased
0

PALANTIR TECHNOLOGIES INC-A

1.6M$290.1M0.4%$85.22+109.88%
14 qtrssince 2022-Q2
Decreased
0

MICRON TECHNOLOGY INC

1.7M$285.3M0.4%$151.01+8.43%
11 qtrssince 2023-Q1
Increased
60
IWFIWF
ETF

ISHARES TR RUSSELL 1000 GROWTH INDEX FUND

586,857$274.9M0.4%$85.12+37.20%
10 qtrssince 2023-Q2
Decreased
0

LOCKHEED MARTIN CORP

549,482$274.3M0.4%$423.82+15.21%
28 qtrssince 2018-Q4
Increased
45

ALNYLAM PHARMACEUTICALS INC

595,926$271.7M0.4%$353.60+28.96%
7 qtrssince 2024-Q1
Increased
55

NEBIUS GROUP NV

2.4M$270.5M0.4%$108.45+1.63%
2 qtrssince 2025-Q2
Increased
59

NVIDIA CORP

1.4M$270.2M0.4%$115.99+56.77%
11 qtrssince 2023-Q1
Decreased
0

MICROSOFT CORP

515,209$266.9M0.4%$351.97+45.93%
10 qtrssince 2023-Q2
Decreased
0

AMAZON.COM INC

1.2M$266.4M0.4%$221.61+0.25%
17 qtrssince 2021-Q3
Decreased
0

CLOUDFLARE INC - CLASS A

1.2M$265.4M0.4%$103.61+110.97%
16 qtrssince 2021-Q4
Decreased
0

REGENERON PHARMACEUTICALS

469,903$264.2M0.4%$624.82-10.37%
5 qtrssince 2024-Q3
Decreased
0
USMVUSMV
ETF

ISHARES EDGE MSCI MIN VOL US

2.7M$260.1M0.4%$92.57+1.90%
3 qtrssince 2025-Q1
Increased
45

BANK OF AMERICA CORP

5M$255.8M0.4%$43.75+16.05%
5 qtrssince 2024-Q3
Decreased
0
$67.2B
AUM
3,628
Positions
Q3 2025
Filing
Rating · 2.5
Quarterly Portfolio Change
+3%Q2'24$42.2B+5%Q3'24$44.2B-2%Q4'24$43.5B+6%Q1'25$46B+21%Q2'25$55.5B+17%Q3'25$65.1B
Activity profile
$ moved · Q3'25
New11%Increased50%Decreased34%Exited5%
Composition
Equity vs derivatives
Equity97%Puts2%Calls1%
Holding period
Avg 4.4 years
<1Q8%1-4Q9%1-2Y7%2Y+76%

TWO SIGMA INVESTMENTS, LP manages $67.2B across 3628 positions as of Q3 2025. Top holdings: SPY (1.0%), XLF (0.9%), XLP (0.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2.5/5.0.

Q3 2025 Summary

Active quarter - 675 new positions, 424 exits, 1458 increased. Top move: XLF (INCREASED, conviction 72). Portfolio: $67.2B across 3628 positions.

Top holdings by portfolio weight

Total AUM$65B
SPY1.01%
XLF0.87%
XLP0.73%
VUG0.62%
QQQ0.60%
QUAL0.56%
IVV0.50%
PLTR0.43%
MU0.42%
IWF0.41%
Other0.41%

Portfolio allocation by GICS sector

Sectors11
Technology17.13%
Financial Services16.82%
Unknown14.25%
Industrials11.38%
Healthcare10.59%
Consumer Cyclical8.73%
Consumer Defensive5.74%
Communication Services5.07%
Energy3.24%
Basic Materials3.08%
Other3.96%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Financial Services, Unknown
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record52
Conviction38
Concentration12
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
AMTBAMTBAMERANT BANCORP INC
Q3 2024 Q2 2026+666,888 shares+$17.1M
8Q
ARCTARCTARCTURUS THERAPEUTICS HLDGS
Q3 2024 Q2 2026+1.1M shares+$7M
8Q
BCRXBCRXBIOCRYST PHARMACEUTICALS INC
Q3 2024 Q2 2026+5.1M shares+$57.4M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used